Michael’s 40-year involvement in cancer research was initiated from his clinical experience as a colorectal surgeon. He has published numerous articles in international journals that cover aspects of epidemiology, screening, molecular biology and biochemistry. Prior to his full time appointment as CEO/CSO of InterK, and in addition to his clinical and academic roles, Michael was actively involved in healthcare administration and management..
Stephen has been involved with all aspects of new product development and commercialisation in the biotech sector for the last thirty years. Prior to his involvement with InterK Stephen patented and subsequently successfully commercialized a range of surgical devices.